NASA pilot David “Nils” Larson outlines X-59 early flight tests, design features, risk management, and planned research phases based on NASA’s Small Steps, Giant Leaps podcast.
Following the successful completion of the NHS national pilot in April 2025, the highly anticipated first results assessing CYP2C19 genetic testing to guide clopidogrel use in ischaemic stroke and TIA ...
The launch comes as the global humanoid robotic industry moves beyond research and development toward commercial trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results